Vycor Medical (VYCO) Gains from Investment Securities (2014 - 2024)
Vycor Medical (VYCO) reported Gains from Investment Securities of -$662.0 for Q1 2024, down 129.86% year-over-year from $2216.9 in Q2 2023, and down 222.14% quarter-over-quarter from $542.0 in Q3 2023.
Vycor Medical (VYCO) Gains from Investment Securities (2014 - 2024) Analysis & Trends
Vycor Medical (VYCO) has 10 years of Gains from Investment Securities data on file, last reported at -$662.0 in Q1 2024.
- Gains from Investment Securities for Q1 2024 came in at -$662.0, down 129.86% year-over-year; the trailing twelve-month figure through Jun 2024 was -$120.0 (up 96.79% YoY), and the FY2020 annual result was $680000.0, down 2.86% from the prior year.
- Gains from Investment Securities declined to -$662.0 in Q1 2024 per VYCO's latest filing, from $542.0 in the prior quarter.
- Over five years, Gains from Investment Securities peaked at $680000.0 in Q1 2020 and troughed at -$3102.0 in Q4 2022.
- A 4-year average of $203933.8 and a median of $223.0 in 2022 frame the typical range for Gains from Investment Securities.
- The sharpest annual moves came in 2023 and 2024: Gains from Investment Securities jumped 664.58% in 2023, then plunged 129.86% in 2024.
- A 4-year view of Gains from Investment Securities shows it stood at $680000.0 in 2020, then plunged by 100.46% to -$3102.0 in 2022, then jumped by 117.47% to $542.0 in 2023, then sank by 222.14% to -$662.0 in 2024.
- Business Quant data shows VYCO's Gains from Investment Securities at -$662.0 in Q1 2024, $542.0 in Q3 2023, and -$254.0 in Q2 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn |
| 10 | Vycor Medical | - | - | 375,153.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2024 | -662.00 |
| Mar 31, 2024 | -662.00 |
| Sep 30, 2023 | 542.00 |
| Sep 30, 2023 | 542.00 |
| Jun 30, 2023 | -254.00 |
| Jun 30, 2023 | -254.00 |
| Mar 31, 2023 | -288.00 |
| Mar 31, 2023 | -288.00 |
| Dec 31, 2022 | -3,102.00 |
| Dec 31, 2022 | -3,102.00 |
| Sep 30, 2022 | -96.00 |
| Sep 30, 2022 | -96.00 |
| Jun 30, 2022 | 3,198.00 |
| Jun 30, 2022 | 3,198.00 |
| Sep 30, 2020 | 680,000.00 |
| Sep 30, 2020 | 680,000.00 |
| Jun 30, 2020 | 680,000.00 |
| Jun 30, 2020 | 680,000.00 |
| Mar 31, 2020 | 680,000.00 |
| Mar 31, 2020 | 680,000.00 |